Skip to main content
Top
Published in: Gastric Cancer 3/2015

01-07-2015 | Original Article

Age and sex interactions in gastric cancer incidence and mortality trends in Korea

Authors: Minkyo Song, Daehee Kang, Jae Jeong Yang, Ji-Yeob Choi, Hyuna Sung, Yunhee Lee, Hyung-Suk Yoon, Yunhee Choi, Seong-Ho Kong, Hyuk-Joon Lee, Han-Kwang Yang, Woo Ho Kim

Published in: Gastric Cancer | Issue 3/2015

Login to get access

Abstract

Background

The incidence and mortality of gastric cancer have declined rapidly over the past few decades, but reverse trends in the young generation's differential between sexes in some races have been reported in recent years. To investigate whether this divergent trend can be observed in Korea, a country with the highest incidence in the world, age- and sex-specific incidence and mortality trends were evaluated.

Methods

Gastric cancer incidence data for the years 1999–2010 and mortality data for the years 1983–2012 were obtained from the Korea Central Cancer Registry and National Statistical Office. Annual percentage changes were calculated by age group (20–39, 40–54, 55–69, 70–79) using Joinpoint regression analysis. Furthermore, age-period-cohort analysis was evaluated.

Results

Overall age-standardized gastric cancer incidence in adults aged between 20 and 79 was declining at a nonsignificant average annual percentage change (AAPC) of −0.2 % in males and −0.4 % in females in Korea during 1999–2010. Mortality was steeper at a significant rate of −4.3 and −5.9 % in males and females, respectively. However, age-specific analysis revealed a flat (males 0.2 %, 95 % CI −0.5–0.6) or increasing incidence trend (females 1.7 %, 95 % CI 0.9–2.5) in the 40–54 age group. APC analysis confirmed the decreasing incidence and mortality trend mainly by the cohort effect.

Conclusions

The differential pattern between males and females in different age groups suggests a possible effect of detection by screening practice or a signal of the change in epidemiological factors in the incidence and mortality of gastric cancer that warrants further studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, S.I., Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available from: http://globocan.iarc.fr. Cited 28 Dec 2013 Ferlay J, S.I., Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available from: http://​globocan.​iarc.​fr. Cited 28 Dec 2013
2.
go back to reference Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27.PubMed Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27.PubMed
3.
go back to reference Kuller LH. Age-adjusted death rates: a hazard to epidemiology? Ann Epidemiol. 1999;9(2):91–2.PubMed Kuller LH. Age-adjusted death rates: a hazard to epidemiology? Ann Epidemiol. 1999;9(2):91–2.PubMed
4.
6.
go back to reference Botterweck AA, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29(4):645–54.PubMedCrossRef Botterweck AA, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29(4):645–54.PubMedCrossRef
7.
go back to reference Sonnenberg A. Time trends of mortality from gastric cancer in Europe. Dig Dis Sci. 2011;56(4):1112–8.PubMedCrossRef Sonnenberg A. Time trends of mortality from gastric cancer in Europe. Dig Dis Sci. 2011;56(4):1112–8.PubMedCrossRef
8.
go back to reference Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut. 2010;59(6):736–43.PubMedCrossRef Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut. 2010;59(6):736–43.PubMedCrossRef
10.
go back to reference Aragones N, et al. Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre. Spain. J Epidemiol Community Health. 1997;51(4):412–7.PubMedCrossRef Aragones N, et al. Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre. Spain. J Epidemiol Community Health. 1997;51(4):412–7.PubMedCrossRef
11.
go back to reference Liu Y, Kaneko S, Sobue T. Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol. 2004;33(4):808–15.PubMedCrossRef Liu Y, Kaneko S, Sobue T. Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol. 2004;33(4):808–15.PubMedCrossRef
16.
go back to reference Shin HR, et al. Nationwide cancer incidence in Korea, 1999–2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37(6):325–31.PubMedCentralPubMedCrossRef Shin HR, et al. Nationwide cancer incidence in Korea, 1999–2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37(6):325–31.PubMedCentralPubMedCrossRef
18.
go back to reference Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Japan: Department of Public Health, Tohoku University of Medicine; 1960. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Japan: Department of Public Health, Tohoku University of Medicine; 1960.
19.
go back to reference Boyle P, Parkin DM. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ. 1991;95:126–58.PubMed Boyle P, Parkin DM. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ. 1991;95:126–58.PubMed
20.
go back to reference Carstensen B, P.M., Hills M, Laara E, A package for statistical analysis in epidemiology. (R package version 1.1.49). 2013. Carstensen B, P.M., Hills M, Laara E, A package for statistical analysis in epidemiology. (R package version 1.1.49). 2013.
21.
go back to reference Kim JI, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol. 2009;21(7):787–93.PubMedCrossRef Kim JI, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol. 2009;21(7):787–93.PubMedCrossRef
22.
go back to reference Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 3;47:1–16, 20. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 3;47:1–16, 20.
23.
go back to reference Chow WH, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90(2):150–5.PubMedCrossRef Chow WH, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90(2):150–5.PubMedCrossRef
24.
go back to reference Khang YH, Park MJ. Trends in obesity among Korean children using four different criteria. Int J Pediatr Obes. 2011;6(3–4):206–14.PubMedCrossRef Khang YH, Park MJ. Trends in obesity among Korean children using four different criteria. Int J Pediatr Obes. 2011;6(3–4):206–14.PubMedCrossRef
25.
go back to reference Oh K, et al. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr. 2008;51(9):950–5.CrossRef Oh K, et al. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr. 2008;51(9):950–5.CrossRef
26.
go back to reference Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.PubMedCrossRef Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.PubMedCrossRef
27.
go back to reference Nam SY, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol. 2009;21(8):855–60.PubMedCrossRef Nam SY, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol. 2009;21(8):855–60.PubMedCrossRef
28.
go back to reference Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011;11(2):69–77.PubMedCentralPubMedCrossRef Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011;11(2):69–77.PubMedCentralPubMedCrossRef
29.
go back to reference Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control. 2005;16(3):285–94.PubMedCrossRef Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control. 2005;16(3):285–94.PubMedCrossRef
30.
go back to reference Freedman ND, et al. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010;46(13):2473–8.PubMedCentralPubMedCrossRef Freedman ND, et al. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010;46(13):2473–8.PubMedCentralPubMedCrossRef
31.
go back to reference Camargo MC, et al. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21(1):20–38.CrossRef Camargo MC, et al. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21(1):20–38.CrossRef
32.
go back to reference Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44(16):2397–403.PubMedCrossRef Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44(16):2397–403.PubMedCrossRef
34.
go back to reference Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002;5(4):213–9.PubMedCrossRef Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002;5(4):213–9.PubMedCrossRef
35.
go back to reference Shiao YH, et al. Microsatellite instability and/or loss of heterozygosity in young gastric cancer patients in Italy. Int J Cancer. 1999;82(1):59–62.PubMedCrossRef Shiao YH, et al. Microsatellite instability and/or loss of heterozygosity in young gastric cancer patients in Italy. Int J Cancer. 1999;82(1):59–62.PubMedCrossRef
36.
go back to reference The Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2010. The Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2010.
Metadata
Title
Age and sex interactions in gastric cancer incidence and mortality trends in Korea
Authors
Minkyo Song
Daehee Kang
Jae Jeong Yang
Ji-Yeob Choi
Hyuna Sung
Yunhee Lee
Hyung-Suk Yoon
Yunhee Choi
Seong-Ho Kong
Hyuk-Joon Lee
Han-Kwang Yang
Woo Ho Kim
Publication date
01-07-2015
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 3/2015
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0411-x

Other articles of this Issue 3/2015

Gastric Cancer 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.